Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

K. Kian Ang, Jonathan Harris, Richard Wheeler et al. · New England Journal of Medicine · 2010 · 6.5K citations · Full text

Medicine, Oncology, Carcinogenesis +9

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

James A. Bonner, Paul M. Harari, J. Giralt et al. · New England Journal of Medicine · 2006 · 5.1K citations · Full text

Medicine, Oncology, Radiation Oncology +13

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau et al. · The Lancet · 2018 · 1.7K citations · Full text

Medicine, Oncology, Pharmacology +11

Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells

Cédric Gaggioli, Steven Hooper, Cristina Hidalgo-Carcedo et al. · Nature Cell Biology · 2007 · 1.6K citations

Life Sciences, Cell Biology, Molecular Biology +14

Physical limits of cell migration: Control by ECM space and nuclear deformation and tuning by proteolysis and traction force

Katarina Wolf, Mariska te Lindert, Marina Krause et al. · The Journal of Cell Biology · 2013 · 1.4K citations · Full text

Natural Sciences, Biophysics, Cell Biology +17